Joseph P. O'Connell
Analyst · Pegasus Capital
Thank you, Everett. Good morning, everyone. I'm very pleased to share with you Astro-Med's financial results for the fourth quarter and for the fiscal 2013. As you heard from Everett and as you know, the company had a very busy fourth quarter and certainly for the whole year in terms of its growth in sales and earnings, as well as the divestiture of the company's Grass Technologies business segment. For this morning's presentation, I will report the financial results on a GAAP basis for the sales, net income and earnings per share for the fourth quarter and for the fiscal year. In the GAAP-based reporting, Grass Technologies will be reported as a discontinued operation due to the divestiture of Grass Technologies business segment. However, I'll also present the company's fourth quarter and the annual results on a non-GAAP basis, including the Grass Technologies business segment. As Everett mentioned before, we believe such a non-GAAP presentation of these results to be a meaningful information and indicative of Astro-Med's operating results across the reporting period. On a GAAP basis, Astro-Med reported sales in the fourth quarter of $16,186,000, representing a 2.4% increase against the sales of $15,810,000 in the fourth quarter of the previous year. Net income in the fourth quarter was $7,489,000, equal to $1 per diluted share. For the corresponding period of the previous year, the company reported net income of $854,000 or $0.11 per diluted share. Net income in the current fourth quarter does include the gain on the sale of the Grass Technologies business segment of $6,216,000 on an after-tax basis or $0.83 per diluted share. Now to report the fourth quarter on a non-GAAP basis. The company achieved record sales revenues of $21,860,000 in the fourth quarter against the sales revenues of $20,429,000 reported in the previous year. The composition of the fourth quarter sales has our QuickLabel Systems at $11,737,000, a record volume for QuickLabel Systems in the fourth quarter and a 15.4% increase over the prior year's fourth quarter QLS sales after excluding the divested North Carolina label business. Our Test & Measurement business segment, including the company's line of ruggedized products, reported sales of $4,449,000 in the quarter, slightly down from the previous year's volume and primarily traceable through the recorder line as the ruggedized products continued to grow during the fourth quarter. The Grass Technologies product group finished strong with sales of $5,674,000. That's a double-digit increase from the previous year. Gross profits on a non-GAAP basis were $9,341,000. That's an 11.7% improvement from last year with a gross profit margin of 42.7%. That's up from the previous year's 41%. Non-GAAP operating income in the fourth quarter was $2,186,000. That's a 34% increment over the previous year's operating income and earned a margin of 10%, again, up from the previous year's margin of 8%. Overall, it was a very strong quarter for Astro-Med. Prior to discussing the balance sheet accounts, a review of the company's annual financial results are as follows: As you may have seen in the company's press release, Astro-Med reported GAAP-based sales for fiscal 2013 of $61,224,000. That's an 8.1% increase from the GAAP-based sales of the previous year after excluding the divested North Carolina label business. Net income on a GAAP basis for the 12-month period of fiscal 2013 was $10,620,000. That's $1.42 per diluted share. The company reported net income of $3,132,000 or $0.42 per diluted share for the previous year. Reporting Astro-Med's annual results on a non-GAAP basis is as follows: Sales for the year were $80,419,000, a new level of revenues reached for the company and a 7.1% increase over the prior year's comparable sales after excluding the divested North Carolina label business. A profile of this year's annual sales is QuickLabel Systems reached $43,588,000. That represents a 10.3% increase over last year, excluding the North Carolina label business. Test & Measurement sales were $17,636,000. That's a single-digit increase over the prior year's, let's say, T&M sales, although the ruggedized product within that component actually was up double-digit. Grass Technologies sales were $19,195,000 for fiscal 2013, again representing a single-digit increase over the prior year. On a non-GAAP basis, the company earned $33,851,000 in gross profits for the year at a margin of 42.1%, again, a nice improvement over the previous year's margin of 40.1%. Non-GAAP operating income was $6,845,000 for the year, again representing a 49% improvement over the previous year's operating income and reflecting an operating margin of 8.5% against the previous year's operating margin of 5.8%. Commenting on the balance sheet at year's end, our cash and marketable security position was $39,508,000. That represents a 71% increase over the prior year's cash position, and obviously, driven by the sale of the Grass Technologies business segment. Accounts receivable balance at year end was $9,376,000, reflecting some 51 days sales outstanding and consistent with the prior year days sales outstanding. Inventory levels dropped slightly at the end of the year to $13,998,000 [ph], representing an improved turnover of 101 days on hand -- I'm sorry, down from the last year's 105 days on hand. Our capital expenditures during fiscal 2013 were $849,000, mostly related to the factory equipment as well as some information technology investments. We paid cash dividends during fiscal 2013 of $2,595,000 to shareholders for the year at $0.35 per share. Astro-Med employee population at year end was 342 persons. That's down some 31 people from the prior year end. On a sales per employee basis, we also improved to a $220,000 per employee. That's up from the prior year's $199,000 per employee. And finally, the company's book value per share rose nicely to $8.64, up from the prior year's book value per share of $7.51. That concludes the financial report for the fourth quarter and for the year. Everett?